TW202102263A - 皮下投予用輸液 - Google Patents

皮下投予用輸液 Download PDF

Info

Publication number
TW202102263A
TW202102263A TW109109944A TW109109944A TW202102263A TW 202102263 A TW202102263 A TW 202102263A TW 109109944 A TW109109944 A TW 109109944A TW 109109944 A TW109109944 A TW 109109944A TW 202102263 A TW202102263 A TW 202102263A
Authority
TW
Taiwan
Prior art keywords
subcutaneous administration
infusion
ions
infusion solution
subcutaneous
Prior art date
Application number
TW109109944A
Other languages
English (en)
Chinese (zh)
Inventor
小林只
米田博輝
大室秀樹
廣田祐輔
原田大輔
林洸仁
森田知樹
品川義之
Original Assignee
日商大塚製藥工場股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商大塚製藥工場股份有限公司 filed Critical 日商大塚製藥工場股份有限公司
Publication of TW202102263A publication Critical patent/TW202102263A/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW109109944A 2019-03-28 2020-03-25 皮下投予用輸液 TW202102263A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2019-064487 2019-03-28
JP2019064487 2019-03-28
JP2019194008 2019-10-25
JP2019-194008 2019-10-25

Publications (1)

Publication Number Publication Date
TW202102263A true TW202102263A (zh) 2021-01-16

Family

ID=72610947

Family Applications (1)

Application Number Title Priority Date Filing Date
TW109109944A TW202102263A (zh) 2019-03-28 2020-03-25 皮下投予用輸液

Country Status (4)

Country Link
JP (1) JP7442206B2 (ja)
CN (1) CN113646043A (ja)
TW (1) TW202102263A (ja)
WO (1) WO2020196381A1 (ja)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7374551B2 (en) * 2003-02-19 2008-05-20 Pittsburgh Plastic Surgery Research Associates Minimally invasive fat cavitation method
JP4430500B2 (ja) * 2003-09-30 2010-03-10 扶桑薬品工業株式会社 炭酸水素イオン含有薬液
CN101721423B (zh) * 2008-10-21 2012-05-23 曾因明 碳酸氢盐生理平衡液及其制备方法
JP6164719B2 (ja) * 2009-10-27 2017-07-19 エイワイファーマ株式会社 白金含有薬剤投与による腎障害の軽減剤
CN107034183A (zh) * 2017-04-13 2017-08-11 安徽瑞杰赛尔生物科技有限公司 制备自体脂肪干细胞生物活性肽冻干粉的方法

Also Published As

Publication number Publication date
JPWO2020196381A1 (ja) 2020-10-01
JP7442206B2 (ja) 2024-03-04
WO2020196381A1 (ja) 2020-10-01
CN113646043A (zh) 2021-11-12

Similar Documents

Publication Publication Date Title
WO1987003808A1 (en) Fluid therapy with l-lactate and/or pyruvate anions
TW200423923A (en) Lactate containing pharmaceutical composition and uses thereof
CN101355953B (zh) 麻醉苏醒促进剂
CN112274525B (zh) 一种化疗药物组合物及其应用
JP2004530659A (ja) 抗腫瘍および抗転移作用のための方法および処方
KR101434329B1 (ko) 체온 저하 억제제
WO2021043120A1 (zh) 一种复方氨基酸双肽注射液及其制备方法和应用
JP6157928B2 (ja) 肝臓への脂肪蓄積抑制剤
CN103977010B (zh) 一种犬用复方赛拉嗪注射剂及其制备方法
TW202102263A (zh) 皮下投予用輸液
CN103432146B (zh) 一种转化糖注射液组合物
EP3616714A1 (en) Lactate-protected hypoglycemia to treat glycolysis dependent pathological conditions, in particular cancer
CN107854426A (zh) 一种新型氨基酸腹膜透析液
CN102441160B (zh) 一种胸腺肽α1药物组合物及其制备方法
CN102885766B (zh) 一种右旋酮洛芬注射液及其制备方法
US10213452B2 (en) Pharmaceutical compositions containing steviosides
CN103830217B (zh) 丙酮酸钠在制备缓解高氯性酸中毒药物中的应用
JP3643879B2 (ja) 電解質輸液組成物
CN102727429B (zh) 改善稳定性的匹多莫德注射液及其制备方法
CN102949413B (zh) 一种转化糖电解质注射液的制备方法
RU2483731C1 (ru) Раствор для инъекций, содержащий налбуфин
Seelig Localized gangrene following the hypodermic administration of calcium chlorid
JP3214116B2 (ja) 術中輸液製剤
Macht CONCERNING THE EFFECT OF SALINE PURGATIVES ON THE ABSORPTION AND EXCRETION OF PHENOLSULPHONPHTHALEIN A PRELIMINARY COMMUNICATION
WO2023121696A1 (en) Formulation and treatment for extended micronutrient therapy